Logo image
The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
Journal article   Open access   Peer reviewed

The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome

Kimberly K Leslie, Kristina W Thiel, Henry D Reyes, Shujie Yang, Yuping Zhang, Matthew J Carlson, Nirmala S Kumar and Donghai D Dai
Obstetrics and Gynecology International, Vol.2013, pp.479541-5
2013
DOI: 10.1155/2013/479541
PMCID: PMC3816067
PMID: 24223042
url
https://doi.org/10.1155/2013/479541View
Published (Version of record) Open Access

Abstract

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor as the most studied biomarker and the best predictor for response for endometrial cancer reported to date.
Review

Details

Metrics

Logo image